Secretion of functional α1-antitrypsin is cell type dependent: Implications for intramuscular delivery for gene therapy.
Secretion of functional α1-antitrypsin is cell type dependent: Implications for intramuscular delivery for gene therapy.
复制标题
功能性α1-抗胰蛋白酶的分泌是细胞类型依赖性的:对基因治疗肌内给药的影响。
DOI:
10.1073/pnas.2206103119
复制
发表时间:
2022-08-02
影响因子:
11.1
通讯作者:
中科院分区:
文献类型:
--
作者:
Protein expression in nonnative cell types is critical for successful gene therapy. Here, we explore the expression of α1-antrypsin (AAT), a gene therapy target, in a variety of cell types and assess the ability of chemical methods to boost its expression. While AAT was efficiently secreted by hepatocytes, its native host, it was poorly expressed in myoblasts and myotubes, although its secretion could be augmented by treatment with the proteostasis regulator suberoylanilide hydroxamic acid, a histone deacetylase inhibitor. The use of proteostasis regulators thus provides a potential strategy to optimize protein expression for a variety of therapeutics. Heterologous expression of proteins is used widely for the biosynthesis of biologics, many of which are secreted from cells. In addition, gene therapy and messenger RNA (mRNA) vaccines frequently direct the expression of secretory proteins to nonnative host cells. Consequently, it is crucial to understand the maturation and trafficking of proteins in a range of host cells including muscle cells, a popular therapeutic target due to the ease of accessibility by intramuscular injection. Here, we analyzed the production efficiency for α1-antitrypsin (AAT) in Chinese hamster ovary cells, commonly used for biotherapeutic production, and myoblasts (embryonic progenitor cells of muscle cells) and compared it to the production in the major natural cells, liver hepatocytes. AAT is a target protein for gene therapy to address pathologies associated with insufficiencies in native AAT activity or production. AAT secretion and maturation were most efficient in hepatocytes. Myoblasts were the poorest of the cell types tested; however, secretion of active AAT was significantly augmented in myoblasts by treatment with the proteostasis regulator suberoylanilide hydroxamic acid, a histone deacetylase inhibitor. These findings were extended and validated in myotubes (mature muscle cells) where AAT was transduced using an adeno-associated viral capsid transduction method used in gene therapy clinical trials. Overall, our study sheds light on a possible mechanism to enhance the efficacy of gene therapy approaches for AAT and, moreover, may have implications for the production of proteins from mRNA vaccines, which rely on the expression of viral glycoproteins in nonnative host cells upon intramuscular injection.
登录
查看更多内容
DOI:
10.1016/j.ymthe.2017.09.020
发表时间:
2017-11-01
期刊:
Molecular therapy : the journal of the American Society of Gene Therapy
影响因子:
--
作者:
Borel F;Tang Q;Gernoux G;Greer C;Wang Z;Barzel A;Kay MA;Shultz LD;Greiner DL;Flotte TR;Brehm MA;Mueller C
通讯作者:
Mueller C
DOI:
10.15252/embj.2020107240
发表时间:
2021-08-02
期刊:
The EMBO journal
影响因子:
--
作者:
Fregno I;Fasana E;Soldà T;Galli C;Molinari M
通讯作者:
Molinari M
影响因子:
3.7
作者:
Fu YL;Han DY;Wang YJ;Di XJ;Yu HB;Mu TW
通讯作者:
Mu TW
影响因子:
4.8
作者:
Bouchecareilh, Marion;Hutt, Darren M.;Balch, William E.
通讯作者:
Balch, William E.
DOI:
10.1513/pats.201001-016aw
发表时间:
2010-11-01
期刊:
Proceedings of the American Thoracic Society
影响因子:
--
作者:
Bouchecareilh, Marion;Conkright, Juliana J;Balch, William E
通讯作者:
Balch, William E